HLNCF saw its Momentum Indicator move below the 0 level on January 08, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 66 similar instances where the indicator turned negative. In of the 66 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for HLNCF turned negative on January 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at .
HLNCF moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.846) is normal, around the industry mean (59.110). P/E Ratio (27.248) is within average values for comparable stocks, (90.460). HLNCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (2.687) is also within normal values, averaging (19.648).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLNCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLNCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BITS | 73.53 | 2.24 | +3.15% |
Global X Blockchain & Bitcoin Str ETF | |||
IWL | 149.57 | 0.65 | +0.44% |
iShares Russell Top 200 ETF | |||
DIAL | 17.73 | 0.05 | +0.28% |
Columbia Diversified Fixed Inc Allc ETF | |||
AFIF | 9.19 | -0.03 | -0.33% |
Anfield Universal Fixed Income ETF | |||
RXD | 10.43 | -0.22 | -2.09% |
ProShares UltraShort Health Care |
A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.
Ticker / NAME | Correlation To HLNCF | 1D Price Change % | ||
---|---|---|---|---|
HLNCF | 100% | -2.30% | ||
HLN - HLNCF | 49% Loosely correlated | +0.42% | ||
SGIOF - HLNCF | 21% Poorly correlated | N/A | ||
STEK - HLNCF | 11% Poorly correlated | +3.49% | ||
EAPIF - HLNCF | 11% Poorly correlated | N/A | ||
ZTS - HLNCF | 10% Poorly correlated | +1.46% | ||
More |
Ticker / NAME | Correlation To HLNCF | 1D Price Change % |
---|---|---|
HLNCF | 100% | -2.30% |
Pharmaceuticals category (307 stocks) | 11% Poorly correlated | +0.32% |
Pharmaceuticals: Other category (221 stocks) | 7% Poorly correlated | +0.47% |